SCHEMBL10154072

SCHEMBL10154072

O=C(NCc1cccs1)C1C(=O)N(OCc2ccccc2)C(=O)c2ccccc21

nearest known ligand 0.52

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
MAPT P10636 2/20 0.52
ALDH1A1 P00352 3/20 0.48
LMNA P02545 1/20 0.45
GLA P06280 1/20 0.44
NPSR1 Q6W5P4 2/20 0.43
GAA P10253 1/20 0.43
POLB P06746 2/20 0.42
KMT2A Q03164 1/20 0.42
HPGD P15428 3/20 0.40
ALOX15 P16050 1/20 0.40
MCHR1 Q99705 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
HSD17B10 Q99714 1/20 0.39
APEX1 P27695 1/20 0.39
CASP6 P55212 1/20 0.39
TDP1 Q9NUW8 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9959313 0.88 KCNA5 (0.48) MAPTALDH1A1LMNAPOLBKMT2A
SCHEMBL9959558 0.82 KCNA5 (0.46) MAPTALDH1A1LMNAKMT2ASMN1; SMN2
SCHEMBL9958824 0.82 ALDH1A1 (0.44) MAPTALDH1A1LMNAPOLBKMT2A
SCHEMBL10153587 0.81 MAPT (0.59) MAPTALDH1A1LMNANPSR1GAA
SCHEMBL9959297 0.81 HDAC4 (0.49) MAPTALDH1A1GAAPOLBKMT2A
SCHEMBL10153642 0.81 KCNA5 (0.42) MAPTALDH1A1LMNANPSR1KMT2A
SCHEMBL10153968 0.80 FAAH (0.39) MAPTALDH1A1LMNAKMT2AALOX15
SCHEMBL9959606 0.79 NPC1 (0.52) MAPTALDH1A1POLBKMT2ASMN1; SMN2
SCHEMBL9958882 0.79 KMT2A (0.46) MAPTALDH1A1LMNANPSR1KMT2A
SCHEMBL9959312 0.79 DRD2 (0.41) MAPTALDH1A1LMNAKMT2ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012085003-A1 2-HYDROXYISOQUINOLINE-1,3(2H,4H)-DIONES AND RELATED COMPOUNDS USEFUL AS HIV REPLICATION INHIBITORS KATHOLIEKE UNIVERSITEIT LEUVEN, K.U. LEUVEN R&D (BE) 2012-06-28 WO disclosed